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Introduction
Mucosal healing has been established as a key therapeutic goal
in management of patients with inflammatory bowel disease
(IBD) that is associated with improved long-term clinical out-
comes, i. e. decreased hospitalization rate and need for corti-
costeroid therapy [1–6]. Therefore, consensus guidelines for
clinical practice and trial endpoints recommend achieving
endoscopic mucosal healing in addition to clinical remission as
a central treatment target [7, 8]. However, substantial disparity
between endoscopic and histological disease activity exists
with several reports showing that white light endoscopy (WLE)
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ABSTRACT
Background and study aims Apart from mucosal healing
as an established treatment goal in inflammatory bowel
diseases (IBD), recent evidence suggests that histologic
healing may become another key prognostic parameter in
IBD patients. We aimed to evaluate whether magnification
endoscopy with optical chromoendoscopy can accurately
assess histologic inflammation in IBD patients.
Patients and methods In this prospective study, 82 pa-
tients with IBD (30 UC, 52 CD) were included. In all patients,
magnification endoscopy in conjunction with optical chro-
moendoscopy was performed and rated on a novel magnifi-
cation endoscopy score by three independent endos-
copists. Targeted biopsies of the imaged areas were obtain-
ed and results were compared against two histological
scores in UC (Robarts Histopathology Index, RHI; Nancy
Histology Index, NHI) and one score in CD (modified Riley
index, mRI). Moreover, interobserver agreement was calcu-
lated.
Results Magnification endoscopy showed strong correla-
tion with histopathologic scoring in both UC (RHI: r = 0.83,
NHI: r = 0.78, P <0.05) and CD (mRI: r =0.74, P <0.05) with
high accuracy, sensitivity, and specificity. Further, 25% of
patients with mucosal healing on standard endoscopy
showed signs of microinflammation on magnification
endoscopy with optical chromoendoscopy, while none of
the patients with mucosal and vascular healing under mag-
nification endoscopy with optical chromoendoscopy exhib-
ited microscopic inflammation. Interobserver agreement
for grading intestinal inflammation by magnification
endoscopy with optical chromoendoscopy was substantial
(κ >0.7).
Conclusion Magnification endoscopy in combination with
optical chromoendoscopy shows strong correlation with
histologic inflammation in patients with IBD. This approach
has potential to reduce physical biopsies for monitoring of
inflammatory activity in patients with IBD during colonos-
copy.
Original article
E1018 Klenske Entcho et al. Magnification endoscopy with… Endoscopy International Open 2019; 07: E1018–E1026
Published online: 08.08.2019
cannot accurately define and detect persistent histologic in-
flammation [9–12]. At the same time, first evidence suggests
that histological remission even better predicts need for corti-
costeroid use and hospitalization than mucosal healing on
endoscopy [13, 14] and based on this evidence, histological
healing has been proposed as another key prognostic param-
eter in IBD patients [15]. However, histological scoring current-
ly is not standardized, 26 different histopathological scores ex-
ist for inflammatory assessment of UC of which only two are va-
lidated [16], and no score is completely representative of pa-
tients with CD [17], resulting in limitations on their direct clin-
ical application.
Further, the process of routinely sending specimens for mi-
croscopic grading of inflammatory activity in clinical practice
is cost- and time-intensive. Recently, initial studies have shown
that magnification endoscopy in combination with optical
chromoendoscopy such as NBI (Olympus, Tokyo, Japan) and i-
scan optical enhancement (i-scan OE, Pentax, Tokyo, Japan)
can accurately identify microscopic inflammation in UC and
show a good correlation with histopathological scoring in this
disease [18, 19].
In this study we aimed to not only verify these results in an
independent cohort but also to extend the finding for the first
to time Crohn’s disease. For this purpose, we assessed whether
magnification endoscopy in combination with i-scan OE can de-
tect histologic inflammation in a large cohort of patients with
IBD with CD and UC using a newly developed magnification
endoscopy score.
Patients and methods
Patients
This was a prospective observational study conducted from
March 2017 to March 2018 at the Ludwig Demling Endoscopy
Center of Excellence at the University Hospital of Erlangen.
The study was approved by the local ethics committee as well
as the Institutional Review Board of the Medical Faculty of the
Friedrich-Alexander University Erlangen-Nuremberg. No min-
ors were included and written informed consent was obtained
from all patients prior to the procedure. Patients with poor
bowel preparation and/or total colectomy were excluded. All
colonoscopies were performed using a high-definition colono-
scope with optical magnification (MagniView, Pentax, Tokyo,
Japan) equipped with the Pentax Medical OPTIVISTA EPK-i7010
video processor (Pentax, Tokyo, Japan).
Extent of inflammation was described according to the Mon-
treal classification [20]. Clinical disease activity for patients
with UC and CD was determined using the Mayo clinical disease
activity score and the Crohn’s disease activity index (CDAI)
[21], respectively. In addition, sociodemographic factors, cur-
rent and past medication along with routine laboratory param-
eters were assessed at the time of colonoscopy.
Endoscopic assessment
Colonoscopies were performed by one colonoscopist experi-
enced in EC and optical diagnosis in IBD (T.R.). Upon WLE exam-
ination, disease activity was scored using the Mayo endoscopic
subscore (Mayo ES, range 0–3) [22] in patients with UC and the
Simple Endoscopic Score for Crohn’s Disease (SES-CD, range
0–60) in patients with CD [23]. Imaging was then switched to
i-scan imaging and optical magnification was used to inspect
the mucosa with 136-fold optical zoom. Evaluation of disease
activity according to the introduced magnification score was
done endoscopically in the segment of the colon with the
most severe disease, from which biopsies were taken for direct
comparison with histopathology. Images and videos under
magnification endoscopy with optical chromoendoscopy from
each patient were digitally stored used for subsequent analy-
ses.
A novel magnification i-scan OE score for grading inflamma-
tory in patients with UC and CD was developed on the basis of a
previous report on magnification endoscopy in UC [19]. Briefly,
in UC, colonic or rectal inflammation were assessed using a mu-
cosal pattern (MP) and vascular pattern (MP) score, which were
each graded on a scale of 1 to 4, and the overall score was cal-
culated as the sum of the mucosal and vascular scores as pre-
viously described [19], therewith ranging from 2 to 8. In CD,
apart from using the same mucosal and vascular scores to as-
sess colonic or rectal inflammation, a separate score was devel-
oped to assess mucosal and vascular changes within the term-
inal ileum under magnification endoscopy in conjunction with
optical chromoendoscopy. Development of the novel magni-
fication score for the terminal ileum was based on the consen-
sus of four IBD-experienced endoscopists (T.R., E.K., R.A. and
M.F.N.), each of whom perform >250 IBD colonoscopies per
year.
From the stored, anonymized magnification images and vid-
eo sequences, post hoc assessment of endoscopic inflamma-
tion and grading was performed according to the newly devel-
oped scores as outlined above. This post-hoc assessment and
grading of inflammatory activity was done independently by a
total of three endoscopists blinded to patient characteristics
and results of histopathological scoring. Finally, interobserver
agreement was calculated using Kappa agreement statistics.
Histopathological assessment
All biopsies were taken from the same regions of interest (ROI)
primarily visualized with i-scan OE. At least two biopsies sample
were taken from each segment according to the standard colo-
noscopic protocol at our department. Histopathological evalu-
ation was done by one experienced gastroinestinal pathologist
(A.H.) blinded to results of endoscopic scoring. For histopatho-
logical scoring, UC Robarts Histopathology Index (RHI) [24] as
well as Nancy histological index (NHI) [25] were used as valida-
ted histology scores. Because there is no validated score for
grading for histological inflammation in patients with CD, we
used a modification of the Riley score [26] as previously de-
scribed by our group in CD [27]. This score represents a modi-
fied version of the common Riley score and apart from includ-
ing the six histological features for ulcerative colitis (acute in-
flammatory cell infiltrate, crypt abscesses, mucin depletion,
surface epithelial integrity, chronic inflammatory cell infiltrate,
crypt architectural irregularities), this score integrates typical
histologic features observed in CD, namely lymphocyte aggre-
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gates, granulomas, and number of eosinophils, thereby asses-
sing a total of nine histologic features [27]. With this, the score
exhibits a total range from 0 to 27 with 0 to 4 corresponding
with histologic remission, a score ≥5 with histological active
disease, 5 to 9 low activity, 10 to 18 moderate activity, and
≥19 high activity [27].
Statistical analysis
Parametric data are expressed in this report as the mean and
SD, and categorical data are presented as percentages. The pri-
mary aim of this study was to assess diagnostic accuracy, sensi-
tivity, and specificity of magnification endoscopy in conjunc-
tion with i-scan OE for assessment of histologic inflammation
in patients with IBD. Therefore, histopathologic scoring was
used as a reference for validation of endoscopic assessment.
Correlation between histology scores and endoscopy scores
used in the study was calculated using Spearman’s correlation
approach. Results are presented as correlation coefficient r,
and P <0.05 was considered to be statistically significant. In
the post hoc phase, the four endoscopists analysed at least
one high-quality image/video of the ROI, represented by the
most affected segment. Fleiss’ kappa statistics (κ) were calcu-
lated to measure interobserver agreement, with >0.75 indicat-
ing very good agreement, 0.4 to 0.75 indicating good agree-
ment, and <0.4 indicating poor agreement. As a study of diag-
nostic accuracy, all statistics are reported according to the
STARD guidelines [28].
Results
Patient characteristics
In total, 82 consecutively enrolled patients with IBD with a
mean disease duration of 11.6 years (UC: 10.1 years, CD: 12.4
years) were included in this study. The study cohort consisted
of 40 males (49%) and 42 females (51%) with a median age of
43 years (range 19 to 72 years). Further demographic details,
clinical patient characteristics and current medication are sum-
marized in ▶Table1. According to the STARD guidelines [28], a
flowchart of the included patients is represented in ▶Fig. 1.
▶ Table 1 Demographic and clinical patient characteristics.
Ulcerative
colitis (n=30)
Crohn’s dis-
ease (n=52)
Age, median (range), years 47 (20–62) 42 (19–72)
Male, n (%) 17 (56.7) 23 (44.2)
Disease duration, mean ± SD
(range), years
10.1 ±7.4 12.4 ± 11.6
Disease extension, n (%)
Proctitis 1 (3.3)
Pancolitis 17 (56.7)
Left sided 12 (40)
Terminal ileum 14 (26.9)
Colonic 10 (19.2)
Ileocolitis 28 (53.9)
Current medication, n (%)
None 0 (0) 8 (15.4)
Mesalazine 10 (33.3) 2 (3.8)
Azathioprine/methotrexate 1 (3.3) 5 (9.6)
Anti-TNF 12 (40) 24 (46.2)
Vedolizumab 6 (20) 2 (3.8)
Ustekinumab 4 (7.7)
Combination therapy 1 (3.3) 3 (5.8)
Steroids 0 (0) 4 (7.7)
Clinical activity scores, n (%)
Mayo score
≤5 21
≥5 9
CDAI
≤150 32
≥150 20
Endoscopic scores, mean ± SD
Mayo score 1.8 ± 1.3
SES-CD 8.4 ± 10.9
Laboratory markers, mean ± SD
C-reactive protein (mg/L) 7 ±7.8 9.4 ±13.5
Patients screened (n = 108)
Patients included (n = 82)
 Ulcerative colitis (n = 30)
▪ clinically healed 
 (n = 10)
▪ clinically not healed 
 (n = 20)
Crohn’s disease (n = 52)
▪ clinically healed 
 (n = 28)
▪ clinically not healed 
 (n = 24)
Patients excluded (n = 26)
▪ poor bowel preparation (n = 5)
▪ anastomotic stenosis (n = 4)
▪ only sigmoidoscopies (n = 17)
▶ Fig. 1 Flowchart of the included patients [28].
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Magnification scores under i-scan OE
In vivo assessment of inflammatory activity in patients with UC
was done according to a previously described score assessing
the vascular and mucosal pattern under magnification endos-
copy in combination with i-scan OE [19]. Endoscopic scoring of
inflammatory activity in the colonic segments of patients with
CD was likewise performed according to this score (▶Table2,
▶Fig. 2) For assessment of disease activity in the terminal ileum
of patients with CD, a new magnification score under i-scan OE
was developed incorporating mucosal and vascular alterations.
For assessment of mucosal pattern (MP) in the terminal ileum,
deformation of the villi as well as presence of erosions, ulcers,
and/or necrosis were evaluated, resulting in an MP score rang-
ing from 1 to 4, where a score of 1 was represented by normal,
leaf-shaped villi, a score of 2 by deformed club-shaped villi, a
score of 3 by club-shaped villi with erosions and a score of 4 by
deformed villi with ulceration and necrosis. Similarly, vascular
pattern (VP) was graded from 1 to 4 based on absence of ves-
sels or a vascular arcade around the villous’ membrane (VP=
1), spiral/serrated vessels inside the villous (VP=2) and pres-
ence of either intravillous (VP=3) or intervillous haemorrhages
(VP=4). Hence, assessing MP and VP in the terminal ileum re-
sulted in a combined overall score (OS) from 2 to 8 (▶Table3,
▶Fig. 3). Examples of active disease under magnification
endoscopy in UC and CD can be found as video files (▶Video
1, ▶Video 2).
During endoscopic scoring, 24 patients (29.3%) were grad-
ed with complete mucosal and vascular healing, defined as a
cumulative score (MP+VP) of 2 under magnification endoscopy
with i-scan OE, 18 patients (21.9%) with light inflammation, 21
patients (25.6%) with moderate inflammation and 19 patients
(23.2%) with severe inflammation. A summary of the assigned
vascular and mucosal i-scan OE magnification scores in the total
cohort is shown in ▶Table4.
▶ Fig. 2 Mucosal and vascular pattern grading in patients with UC and CD in the colon under magnification endoscopy with i-scan OE. Upper
row: Grading of the mucosal pattern was based on a scoring from 1 to 4, as outlined in ▶Table 2. Lower row: Grading of the vascular pattern
was based on a scoring from 1 to 4, as outlined in ▶Table 2.
▶ Table 2 i-scan OE magnification endoscopy score for UC and CD in
the colon [19].
Score Characteristics
Vascular pattern (VP) score
VP Grade 1 Round vessels surrounding crypts, isolated spiral
vessels
VP Grade 2 Crowded/tortuous/serrated vessels
VP Grade 3 Dilated vessels with intramucosal bleeding
VP Grade 4 Destroyed vessels with luminal bleeding
Mucosal pattern (MP) score
MP Grade 1 Round/dilated/absent crypts
MP Grade 2 Round crypts with microerosion
MP Grade 3 Dilated/elongated crypts with erosion
MP Grade 4 Hyperplastic crypts with necrosis and ulcers
Overall score Mucosal + vascular pattern score
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Correlation with histopathology
Overall, magnification i-scan OE scoring showed significant cor-
relation with the Mayo ES and the SES-C with an r =0.9 (95% CI:
0.8–0.95, P<0.05) and an r = 0.92 (95% CI: 0–86–0-95, P<
0.05), respectively. However, of 32 patients as classified as hav-
ing achieved mucosal healing under standard WLE (UC: Mayo
ES≤1, CD: absence of erosions or ulcerations), 8 patients
(25 %) exhibited persistent abnormal VP and MP scoring as as-
sessed by magnification endoscopy with i-scan OE. Respective
vascular and mucosal magnification scores under i-scan OE of
the patients with mucosal healing under WLE are shown in
▶Table5.
In contrast, of 24 patients who had complete mucosal and
vascular healing under magnification endoscopy in combina-
tion with i-scan OE (MP+VP=2), none showed signs of inflam-
mation in histopathological assessment.
When compared with RHI, scoring under magnification
endoscopy with i-scan OE showed very strong correlation with
an r =0.83 (95% CI: 0.66–0-92, P<0.05). Correspondingly, his-
tologic scoring with NHI also showed strong and significant cor-
relation with scoring under magnification endoscopy with an r
= 0.78 (95% CI: 0.57–0-89, P <0.05). In CD, assessing MP and
VP under magnification endoscopy with i-scan OE showed a
strong correlation with histopathological scoring according to
the modified RI (r = 0.74, 95% CI: 0.58–0-85, P <0.05).
Diagnostic sensitivity, specificity, and accuracy of assessing
inflammation with magnification endoscopy together with i-
scan OE for the different histologic scores as well as correlation
with histopathology in comparison to WLE are summarized in
▶Table6.
Of note, 2 of 30 UC patients exhibited inflammation under
WLE of the terminal ileum, i. e. backwash ileitis. In these pa-
▶ Fig. 3 Mucosal and vascular pattern grading in patients with CD in the terminal ileum under magnification endoscopy with i-scan OE. Upper
row: Grading of the mucosal pattern was based on a scoring from 1 to 4, as outlined in▶Table3. Lower row: Grading of the vascular pattern was
based on a scoring from 1 to 4, as outlined in ▶Table3.
▶ Table 3 i-scan OE magnification endoscopy score for CD in the term-
inal ileum.
Score Characteristics
Vascular pattern (VP) score
VP Grade 1 No vessels visible or vascular arcade within the villi
VP Grade 2 Spiral/serrated vessels inside the villi
VP Grade 3 Intravillous haemorrhage
VP Grade 4 Intervillous haemorrhage and/or vascular distortion
with areal bleeding
Mucosal pattern (MP) score
MP Grade 1 Normal villi
MP Grade 2 Deformed, hypertrophied villi with irregular size,
shape and distance
MP Grade 3 Deformed, hypertrophied villi with erosions
MP Grade 4 Deformed, hypertrophied villi with ulcerations and
necrosis
Overall score Mucosal + vascular pattern score
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tients, inflammatory assessment under magnification endos-
copy with i-scan OE correlated perfectly with histopathology.
Interobserver agreement
Interobserver agreement between the three endoscopists who
scored the collected images/videos was calculated, culminat-
ing in a κ statistic of 0.76 (95%CI 65–84). According to the pre-
viously described interpretation of kappa values, this indicates
“very good” agreement between the endoscopists for asses-
sing inflammatory activity under magnification endoscopy in
combination with i-scan OE.
Discussion
In this study, we showed that magnification endoscopy in con-
junction with i-scan OE as a novel virtual chromoendoscopy
(VC) technique shows strong correlation with histologic inflam-
mation in patients with IBD. Of note, of 32 patients who were
considered to have achieved mucosal healing on conventional
WLE, 25% had persistent microscopic inflammation on histopa-
thology, and even more importantly, this residual microscopic
inflammation correlated to an abnormal mucosal or vascular
pattern under magnification endoscopy in conjunction with
i-scan OE. In contrast, of the 24 patients whp had complete
mucosal and vascular healing under magnification endoscopy,
none exhibited microscopic inflammation on histopathologi-
cal scoring.
These findings have several important implications: First, al-
though mucosal healing as assessed by conventional WLE is an
established treatment goal that is associated with improved
long-term outcome in patients with IBD [2], accumulating evi-
dence suggests histological remission might serve as an even
better predictor of patient outcomes, especially with regard to
corticosteroid use and hospitalization rates than mucosal heal-
ing [13, 14]. Therefore, the international organization for the
study of inflammatory bowel diseases (IOIBD) has already pro-
posed histologic healing as another key treatment goal in IBD
patients [15]. Given these considerations, it seems clear that
endoscopic techniques that can precisely assess microscopic
inflammation can facilitate and improve patient care and deci-
sion-making about medical therapy. Second, the most com-
monly used current scoring systems, such as Mayo ES in UC or
SES-CD, mainly implement mucosal abnormalities such as pres-
ence of erosions or ulcerations, mucosal friability, presence of
stenosis or surface affected by any lesions while vascular ab-
normalities are typically underrepresented within these scores.
Altered vasculature, however, is a frequently observed finding
in patients with IBD with certain clinical relevance. A variety of
studies have shown that mucosal angiogenesis not only plays
Video 1 Active UC during magnification endoscopy. Note the
presence of spiral/serrated vessels around the colonic crypts.
Video 2 Active CD during magnification endoscopy. Note the
presence of intervillous hemorrhages.
▶ Table 4 Magnification endoscopy scoring in the whole IBD cohort.
Score Mucosal pattern Vascular pattern
1 36 31
2 12 15
3 12 25
4 22 11
▶ Table 5 Patients with mucosal healing under WLE (n =32) and their
corresponding mucosal and vascular pattern scoring with magnifica-
tion endoscopy and i-scan OE.
Score Mucosal pattern Vascular pattern
1 25 24
2 5 5
3 2 3
4 0 0
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an important role in the initiation and perpetuation of chronic
intestinal inflammation commonly associated with IBD [29–
31] but also that increased vascular density in IBD directly cor-
relates with disease severity [32]. More recent endoscopic
scores, such as The Ulcerative Colitis Endoscopic Index of Sever-
ity (UCEIS) [33], already address this and incorporated altera-
tions of the vascular pattern with a distinction between normal,
patchy, and complete obliteration for grading disease activity.
However, this is an evaluation that is based on conventional as-
sessment with WLE while at the same time, a recent study pro-
vides evidence that only magnification endoscopy in conjunc-
tion with NBI unmasked a certain vascular pattern that served
as an important endoscopic predictive feature of clinical recur-
rence in patients with UC [18]. Third, consistent with previous
reports [18, 19], our results corroborate that magnification
endoscopy in conjunction with optical chromoendoscopy can
render endoscopic diagnosis of inflammatory activity more
precisely and closer to histology in patients with UC and now il-
lustrate at the same time that the same approach can be readily
applied in patients with CD likewise to successfully assess mi-
croscopic inflammation.
Interestingly, in our study 2 of 30 patients with UC exhibited
inflammation under WLE of the terminal ileum, i. e. backwash
ileitis. In these patients, inflammatory assessment under mag-
nification endoscopy with i-scan OE was made according to the
introduced score (▶Fig. 3, ▶Table 3) and correlated perfectly
with histopathology. In the future, magnification endoscopy in
combination with i-scan OE might be useful to detect backwash
ileitis otherwise not visible under WLE in patients with UC.
Advanced endoscopic imaging techniques for inflammatory
assessment in IBD can be roughly divided into dye-based and
dye-less chromoendoscopy [34, 35] and results for assessing
IBD-associated intestinal inflammation have been summarized
recently in a systematic review [6]. One of the earliest prospec-
tive studies in 30 patients with UC identified specific vascular
patterns under NBI which were associated with acute inflam-
matory cell infiltrates, goblet cell depletion, and basal plasma-
cytosis on histopathology, thereby providing evidence that NBI
during colonoscopy may allow a more precise grading of muco-
sal alterations [31]. The role of NBI combined with magnifica-
tion endoscopy for assessment of histologic inflammation has
also been assessed. In this regard, it has been shown that mag-
nification endoscopy together with NBI can identify branch-like
structures and the vascular architecture of the domes in Peyer’s
patches in IBD patients [36] and that presence of a certain vas-
cular pattern indicates histopathological activity and is asso-
ciated with disease relapse [18]. Apart from studies on NBI, an-
other recent study also demonstrated that magnification
endoscopy together with optical enhancement can accurately
assess histologic inflammation in 41 patients with UC [19]. In
this report, we not only confirmed these results but also extend
this to patients with CD. In their totality, our results together
with the studies discussed above indicate that optical assess-
ment of the mucosa in patients with IBD is feasible at almost
histological level using magnification endoscopy and optical
chromoendoscopy. Therefore, these techniques represent a
powerful addition to the diagnostic armamentarium of the co-
lonoscopist screening patients with IBD for their disease activ-
ity that hold the potential to reduce the number of physical
biopsies required during screening colonoscopies for monitor-
ing disease activity in patients with IBD.
Although this prospective study included a large number of
patients with IBD, potential limitations also need to be addres-
sed, one of which is the fact that all colonoscopies were per-
formed by a single experienced endoscopist at a single center.
However, this is partly due to the fact that magnification endos-
copy is currently not widely available in Europe and clearly, mul-
ticenter and multi-operator studies will be needed to corrobo-
rate these findings. Further potential limitations should also be
mentioned. This is a pilot study with only a restricted amount of
patients and larger cohorts are needed to further reaffirm the
ability of magnification endoscopy in combination with i-scan
▶ Table 6 Correlation between magnification endoscopy scoring, histopathological scoring and WLE.
Ulcerative colitis
ME/i-scan OE and RHI ME/i-scan OE and NHI WLE and RHI WLE and NHI
Accuracy, % 82 71 57 54
Sensitivity, % (95% CI) 88.2 (62–98) 76.5 (50–92) 69.2 (39–90) 68 (41–88)
Specificity, % (95% CI) 63.6 (32–88) 63.6 (32–88) 33 (13–61) 33 (11–65)
Correlation r (95% CI) 0.83 (0.66–0.92) 0.78 (0.57–0.89) 0.67 (0.39–0.83) 0.62 (0.32–0.82)
Crohn’s disease
ME/i-scan OE and mRI WLE and mRI
Accuracy, % 67 55
Sensitivity, % (95% CI) 76.2 (53–91) 52.2 (31–73)
Specificity, % (95% CI) 60.7 (41–78) 57.6 (37–76)
Correlation r (95% CI) 0.74 (0.58–0.85) 0.68 (0.49–0.81)
ME, magnification endoscopy; RH,: Robarts histological Index [24]; NH,: Nancy histological Index [25]; mRI, modified Riley Index [27]; WLE: white-light endoscopy.
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OE for detection of microinflammation in IBD patients. Initial
studies on new technologies in academic hospitals are known
to demonstrate better outcomes as compared to studies in rou-
tine clinical practice outside academic centers [37], therefore,
performance of this technique might deteriorate when used
by community based endoscopists. Correlation for a scoring
system rated by the developers might be prone to a certain
bias, and correlation might be decreased when used by endos-
copists outside our expert group. An additional limitation of
this study is that histologic inflammation might not be fully re-
presented by and correlated with endoscopically observed in-
flammation. In patients with CD, inflammation is known to
vary even in the same colonic segment, making a direct com-
parison between histologic and endoscopic inflammation chal-
lenging. More specifically, transmural inflammation might not
be represented in our magnification score for CD. In our study,
the most severe enteric segment was evaluated as representa-
tive of underlying inflammation.
Conclusion
In summary, our results show that i-scan OE together with
magnification endoscopy shows strong correlation with histo-
logic inflammation in both patients with UC and with CD, there-
fore rendering the endoscopic diagnosis more precise, espe-
cially in patients who exhibit mucosal healing under conven-
tional WLE.
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